FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula 
(I), where X is O or S; R1 represents C1-10 alkyl, C3-10 cycloalkyl, which is optionally substituted with from one to three lower alkyls, (lower alkylene)-(C3-10 cycloalkyl, which is optionally substituted with from one to three lower alkyls), or -(lower alkylene)-phenyl; R2 represent H; R3 represents C1-10 alkyl, -(lower alkylene)-O-(lower alkenyl), -(lower alkylene)-(C3-8 cycloalkyl), -(lower alkylene)-O-(lower alkylene)-(C3-8 cycloalkyl), -(lower alkylene)-S-(lower alkyl), -(lower alkylene)-S-(lower alkylene)-(C3-8 cycloalkyl), or -(lower alkylene)-O-(pyridyl, optionally substituted with from one to five halogens); RP represents H; and R6 represents H.
EFFECT: invention can be used as a medicine for the treatment of nocturia, based on the inhibition of P-LAP.
8 cl, 1 dwg, 9 tbl, 294 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FURO[3,2-C]PYRIDINE OR THIENO[3,2-C]PYRIDINE DERIVATIVES USEFUL IN TREATING NOCTURIA | 2015 |
|
RU2700411C2 |
| THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2015 |
|
RU2733405C2 |
| NOVEL COMPOUNDS THAT ARE ERK INHIBITORS | 2013 |
|
RU2660429C2 |
| 1-PHENYL-2-PYRIDINYLALKYL ALCOHOLS DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | 2012 |
|
RU2626956C2 |
| 2-AMINOTHIAZOLE DERIVATIVE OR SALT THEREOF | 2015 |
|
RU2702106C2 |
| FGFR AND ITS MUTATION INHIBITOR, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2811207C1 |
| AZULENE DERIVATIVE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT OF DIABETES MELLITUS | 2003 |
|
RU2295522C2 |
| BICYCLIC ARYL MONOBACTAM COMPOUNDS AND METHODS OF USING SAID COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | 2017 |
|
RU2733402C2 |
| NOVEL PYRIDINE DERIVATIVE AND DERIVATIVE OF PYRIMIDINE (3) | 2006 |
|
RU2362771C1 |
| β-D-2ʹ-DEOXY-2ʹ-α-FLUORO-2ʹ-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR TREATMENT OF DISEASES CAUSED BY HCV | 2016 |
|
RU2764767C2 |
